Influence of Delayed Zoledronic Acid Initiation on Disease-Free Survival in Postmenopausal Women with Endocrine Receptor-Positive Early Breast Cancer Receiving Adjuvant Letrozole: Exploratory Analyses from the ZO-FAST Trial

被引:1
|
作者
Coleman, R. [1 ]
De, Boer R. [1 ]
Eidtmann, H. [1 ]
Neven, P. [1 ]
von Minckwitz, G. [1 ]
Martin, N. [1 ]
Modi, A. [1 ]
Bundred, N. [1 ]
机构
[1] Univ Sheffield, Sheffield, S Yorkshire, England
关键词
D O I
10.1158/0008-5472.SABCS11-P2-17-01
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P2-17-01
引用
收藏
页数:1
相关论文
共 37 条
  • [1] Impact of Zoledronic Acid in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: Z-FAST, ZO-FAST, and E-ZO-FAST
    Coleman, R.
    Bundred, N.
    De Boer, R.
    Llombarto, A.
    Campbell, I
    Neven, P.
    Barrios, C.
    Dias, R.
    Miller, J.
    Brufsky, A.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 733S - 733S
  • [2] Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study
    Eidtmann, H.
    de Boer, R.
    Bundred, N.
    Llombart-Cussac, A.
    Davidson, N.
    Neven, P.
    von Minckwitz, G.
    Miller, J.
    Schenk, N.
    Coleman, R.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 (11) : 2188 - 2194
  • [3] Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results
    Coleman, R.
    de Boer, R.
    Eidtmann, H.
    Llombart, A.
    Davidson, N.
    Neven, P.
    von Minckwitz, G.
    Sleeboom, H. P.
    Forbes, J.
    Barrios, C.
    Frassoldati, A.
    Campbell, I.
    Paija, O.
    Martin, N.
    Modi, A.
    Bundred, N.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 (02) : 398 - 405
  • [5] The ZO-FAST trial: zoledronic acid effectively inhibits aromatase inhibitor associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: 24 month BMD results
    Deboerr, R.
    Eidtmann, H.
    Pinotti, G.
    Miller, J.
    Schenk, N.
    Dias, R.
    Coleman, R.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S36 - S36
  • [6] The effect of zoledronic acid on aromatase inhibitor associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36 months follow-up of ZO-FAST
    Eidtmann, H.
    Bundred, N. J.
    DeBoer, R.
    Llombart, A.
    Davidson, N.
    Neven, P.
    von, Minckwitz G.
    Miller, J.
    Schenk, A.
    Coleman, R.
    [J]. CANCER RESEARCH, 2009, 69 (02) : 74S - 74S
  • [7] Long-Term Survival Outcomes among Postmenopausal Women with Hormone Receptor-Positive Early Breast Cancer Receiving Adjuvant Letrozole and Zoledronic Acid: 5-Year Follow-Up of ZO-FAST.
    de Boer, R.
    Bundred, N.
    Eidtmann, H.
    Neven, P.
    von Minckwitz, G.
    Martin, N.
    Modi, A.
    Coleman, R.
    [J]. CANCER RESEARCH, 2011, 71
  • [8] The effect of zoledronic acid in postmenopausal women (PMW) with early breast cancer (EBC) receiving adjuvant letrozole: 24 months integrated follow-up of the Z-FAST/ZO-FAST trials
    Frassoldati, A.
    Brufsky, A.
    Bundred, N.
    Lambert-Falls, R.
    Hadji, P.
    Schenk, N.
    Paija, O.
    Mena, R.
    Coleman, R.
    [J]. BREAST, 2009, 18 : S51 - S52
  • [10] The Effect of Zoledronic Acid on Aromatase Inhibitor Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: The ZO-FAST Study 5-Year Final Follow-Up
    DeBoer, R.
    Bundred, N.
    Eidtmann, H.
    Llombert, A.
    Neven, P.
    von Minckwitz, G.
    Martin, N.
    Modi, A.
    Coleman, R.
    [J]. CANCER RESEARCH, 2010, 70